Cormorant Private Healthcare Fund II, 10% Owner of MoonLake Immunotherapeutics MLTX, has filed 4 purchases and 6 sales on the open market. The latest trade was on 25/09/30.

CI

CI

Cormorant Private Healthcare Fund II

Former 10% Owner

Company

MoonLake Immunotherapeutics MLTX

First filing

23/06/26

Trades

11 trades

Buys / sales

4 / 6

12-month net buying

No record

Last trade

25/09/30

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
MoonLake ImmunotherapeuticsMLTX	Open-market sale	25/09/29–25/09/30	25/10/01	6,499,978 sh5 trades	$7.21avg.	$46,868,184.1	−76.5%
MoonLake ImmunotherapeuticsMLTX	Open-market buy	23/10/05	23/10/10	58,839 sh	$59.90	$3,524,456.1	+0.7%
MoonLake ImmunotherapeuticsMLTX	Open-market buy	23/10/02–23/10/04	23/10/04	293,212 sh3 trades	$57.30avg.	$16,800,123.3	+3.6%
GP GreenLight Biosciences Holdings, PBC	Open-market sale	23/07/20	23/07/24	9,188,659 sh	$0.00	$0	−100.0%